Clinical Trials
593
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (212 trials with phase data)• Click on a phase to view related trials
Long-Term Neurologic and Neurocognitive Sequelae Following Pediatric Ebola Virus in Liberia
- Conditions
- EbolaPost-Acute Ebola Syndrome
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-07-17
- Target Recruit Count
- 410
- Registration Number
- NCT06811129
- Locations
- 🇱🇷
John F. Kennedy Medical Center, Monrovia, Liberia
Predicting Future Errors During Skill Performance
- Conditions
- Healthy
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2025-07-17
- Target Recruit Count
- 40
- Registration Number
- NCT06707207
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
A Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes
- Conditions
- Myasthenic Syndromes, Congenital
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2025-05-16
- Target Recruit Count
- 75
- Registration Number
- NCT06630650
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
- Conditions
- StrokeBrain DiseaseVascular DiseasesCerebrovascular Disorder
- First Posted Date
- 2024-09-27
- Last Posted Date
- 2025-07-17
- Target Recruit Count
- 450
- Registration Number
- NCT06615973
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
- Conditions
- PASC Post Acute Sequelae of COVID-19
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2025-06-13
- Target Recruit Count
- 12
- Registration Number
- NCT06577467
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 119
- Next
News
Uric Acid Shows Promise as Novel Add-On Therapy for Ischemic Stroke in NIH-Funded Study
NIH-funded preclinical research demonstrates that uric acid treatment significantly improved sensorimotor function and survival rates in rodents 30 days after ischemic stroke.
UVA Launches $30M Trial to Test Ketamine for Life-Threatening Seizures
The University of Virginia has secured a $9.3 million NIH grant as initial funding for a $30 million clinical trial investigating ketamine's potential in treating status epilepticus, a life-threatening seizure condition.
Newer Epilepsy Medications During Pregnancy Show No Impact on Children's Neurodevelopment at Age 6
A recent study indicates that newer anti-seizure medications, like lamotrigine and levetiracetam, pose no significant risk to children's language development when taken during pregnancy.
NIH Collaboratory Adds APA-SM Trial to Evaluate Acupressure for Chronic Pain Management
The NIH Pragmatic Trials Collaboratory welcomes the APA-SM trial, focusing on personalized auricular point acupressure for chronic pain self-management in rural areas.